Related Experiment Video
Updated: May 17, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
RNA polymerase III repression by the retinoblastoma tumor suppressor protein
Alison Gjidoda1, R William Henry
1Department of Biochemistry & Molecular Biology, Michigan State University, 603 Wilson Road, East Lansing, MI 48824, USA.
Abstract:
The retinoblastoma (RB) tumor suppressor protein regulates multiple pathways that influence cell growth, and as a key regulatory node, its function is inactivated in most cancer cells. In addition to its canonical roles in cell cycle control, RB functions as a global repressor of RNA polymerase (Pol) III transcription. Indeed, Pol III transcripts accumulate in cancer cells and their heightened levels are implicated in accelerated growth associated with RB dysfunction. Herein we review the mechanisms of RB repression for the different types of Pol III genes. For type 1 and type 2 genes, RB represses transcription through direct contacts with the core transcription machinery, notably Brf1-TFIIIB, and inhibits preinitiation complex formation and Pol III recruitment. A contrasting model for type 3 gene repression indicates that RB regulation involves stable and simultaneous promoter association by RB, the general transcription machinery including SNAPc, and Pol III, suggesting that RB may impede Pol III promoter escape or elongation. Interestingly, analysis of published genomic association data for RB and Pol III revealed added regulatory complexity for Pol III genes both during active growth and during arrested growth associated with quiescence and senescence. This article is part of a Special Issue entitled: Transcription by Odd Pols.
Insights
The retinoblastoma (RB) protein suppresses RNA polymerase III (Pol III) transcription, and its dysfunction in cancer leads to increased Pol III transcripts, promoting tumor growth. This review details RB
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Regulation
Background:
- The retinoblastoma (RB) protein is a crucial tumor suppressor regulating cell growth.
- RB dysfunction is common in cancer, leading to uncontrolled cell proliferation.
- RB globally represses RNA polymerase III (Pol III) transcription.
Purpose of the Study:
- To review the mechanisms by which RB represses different types of Pol III genes.
- To explore the role of RB-mediated Pol III repression in cancer growth.
- To discuss the regulatory complexity of Pol III genes under different cellular conditions.
Main Methods:
- Review of existing literature on RB function and Pol III transcription.
- Analysis of published genomic association data for RB and Pol III.
- Discussion of molecular mechanisms for RB repression of Pol III genes.
Main Results:
- RB represses type 1 and 2 Pol III genes via direct interaction with transcription factors, inhibiting preinitiation complex formation.
- RB represses type 3 Pol III genes through stable promoter association, potentially impeding Pol III escape or elongation.
- Genomic data reveal complex RB and Pol III regulation during active growth, quiescence, and senescence.
Conclusions:
- RB's repression of Pol III transcription is a key mechanism in cell growth control.
- Dysfunctional RB in cancer leads to elevated Pol III transcripts, contributing to tumor progression.
- Understanding these mechanisms offers insights into cancer development and potential therapeutic strategies.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Experimental RNAi
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
